Iron-chelation therapy with oral chelators in patients with thalassemia major

By Uygun Vedat  

Hematology, Vol. 18, Iss. 1, 2013-01 ,pp. : 50-55

Maney Publishing

Access to resources Recommend Favorite

Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience

By El-Beshlawy Amal   Manz Chantal   Naja Mohammed   Eltagui Mona   Tarabishi Claudia   Youssry Ilham   Sobh Hewida   Hamdy Mona   Sharaf Iman   Mostafa Azza   Shaker Olfat   Hoffbrand A.   Taher Ali  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 545-550

Springer Publishing Company

Access to resources Recommend Favorite

The Sydney Children's Hospital experience with the oral iron chelator deferiprone (L1)

By Berdoukas V.   Bohane T.   Eagle C.   Lindeman R.   DeSilva K.   Tobias V.   Painter D.   Fraser I.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 239-240

Elsevier

Access to resources Recommend Favorite

Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience

By Abdelrazik Nabil  

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 577-585

Maney Publishing

Access to resources Recommend Favorite

Combined use of oral chelators and desferrioxamine in thalassemia

By Piga A   Roggero S   Marletto F   Sacchetti L   Longo F  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 89-91

Maney Publishing

Access to resources Recommend Favorite